Neal Parikh

Dr. Neal Parikh


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2020 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
ELE. Lin
E. Lin
JLJ.E. Lantos
J.E. Lantos
SSS.B. Strauss
S.B. Strauss
CPC. Douglas Phillips
C. Douglas Phillips
TCT.R. Campion
T.R. Campion
AGA. Gupta
A. Gupta
BACKGROUND AND PURPOSE: A large spectrum of neurologic disease has been reported in patients with coronavirus disease 2019 (COVID-19) infection. Our aim was to investigate the yield of neuroimaging in patients with COVID-19 undergoing CT or MR imaging of the brain and to describe associated imaging findings. MATERIALS AND METHODS: We performed a retrospective cohort study involving 2054 patients with laboratory-confirmed COVID-19 presenting to 2 hospitals in New York City between March 4 and May 9, 2020, of whom 278 (14%) underwent either CT or MR imaging of the brain. All images initially received a formal interpretation from a neuroradiologist within the institution and were subsequently reviewed by 2 neuroradiologists in consensus, with disputes resolved by a third neuroradiologist. RESULTS: The median age of these patients was 64 years (interquartile range, 50–75 years), and 43% were women. Among imaged patients, 58 (21%) demonstrated acute or subacute neuroimaging findings, the most common including cerebral infarctions (11%), parenchymal hematomas (3.6%), and posterior reversible encephalopathy syndrome (1.1%). Among the 51 patients with MR imaging examinations, 26 (51%) demonstrated acute or subacute findings; notable findings included 6 cases of cranial nerve abnormalities (including 4 patients with olfactory bulb abnormalities) and 3 patients with a microhemorrhage pattern compatible with critical illness–associated microbleeds. CONCLUSIONS: Our experience confirms the wide range of neurologic imaging findings in patients with COVID-19 and suggests the need for further studies to optimize management for these patients.

13 May 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
HKHooman Kamel
Hooman Kamel
NPNeal Parikh
Neal Parikh
ACAbhinaba Chatterjee
Abhinaba Chatterjee
LKLuke K. Kim
Luke K. Kim
JSJeffrey L Saver
Jeffrey L Saver
BNBabak B. Navi
Babak B. Navi
Background and Purpose: Mechanical thrombectomy helps prevent disability in patients with acute ischemic stroke involving occlusion of a large cerebral vessel. Thrombectomy requires procedural expertise and not all hospitals have the staff to perform this intervention. Few population-wide data exist regarding access to mechanical thrombectomy. Methods: We examined access to thrombectomy for ischemic stroke using discharge data from calendar years 2016 to 2018 from all nonfederal emergency departments and acute care hospitals across 11 US states encompassing 80 million residents. Facilities were classified as hubs if they performed mechanical thrombectomy, gateways if they transferred patients who ultimately underwent mechanical thrombectomy, and gaps otherwise. We used standard descriptive statistics and unadjusted logistic regression models in our primary analyses. Results: Among 205 681 patients with ischemic stroke, 100 139 (48.7% [95% CI, 48.5%–48.9%]) initially received care at a thrombectomy hub, 72 534 (35.3% [95% CI, 35.1%–35.5%]) at a thrombectomy gateway, and 33 008 (16.0% [95% CI, 15.9%–16.2%]) at a thrombectomy gap. Patients who initially received care at thrombectomy gateways were substantially less likely to ultimately undergo thrombectomy than patients who initially received care at thrombectomy hubs (odds ratio, 0.27 [95% CI, 0.25–0.28]). Rural patients had particularly limited access: 27.7% (95% CI, 26.9%–28.6%) of such patients initially received care at hubs versus 69.5% (95% CI, 69.1%–69.9%) of urban patients. For 93.8% (95% CI, 93.6%–94.0%) of patients with stroke at gateways, their initial facility was capable of delivering intravenous thrombolysis, compared with 76.3% (95% CI, 75.8%–76.7%) of patients at gaps. Our findings were unchanged in models adjusted for demographics and comorbidities and persisted across multiple sensitivity analyses, including analyses adjusting for estimated stroke severity. Conclusions: We found that a substantial proportion of patients with ischemic stroke across the United States lacked access to thrombectomy even after accounting for interhospital transfers. US systems of stroke care require further development to optimize thrombectomy access.

1 November 2016 in Stroke
Verified
Journal Article
Closed access
PDF file
NPNeal Parikh
Neal Parikh
JCJoséphine Cool
Joséphine Cool
MKMaria G. Karas
Maria G. Karas
ABAmelia K. Boehme
Amelia K. Boehme
HKHooman Kamel
Hooman Kamel
Background and Purpose—: Ventricular assist devices (VADs) have advanced the management of end-stage heart failure. However, these devices are associated with hemorrhagic and thrombotic complications, including stroke. We assessed the incidence, risk factors, and outcomes of ischemic and hemorrhagic stroke after VAD placement. Methods—: Using administrative claims data from acute care hospitals in California, Florida, and New York from 2005 to 2013, we identified patients who underwent VAD placement, defined by the International Classification of Diseases, Ninth Revision, Clinical Modification code 37.66. Ischemic and hemorrhagic strokes were identified by previously validated coding algorithms. We used survival statistics to determine the incidence rates and Cox proportional hazard analyses to examine the associations. Results—: Among 1813 patients, we identified 201 ischemic strokes and 116 hemorrhagic strokes during 3.4 (±2.0) years of follow-up after implantation of a VAD. The incidence of stroke was 8.7% per year (95% confidence interval [CI], 7.7–9.7). The annual incidence of ischemic stroke (5.5%; 95% CI, 4.8–6.4) was nearly double that of hemorrhagic stroke (3.1%; 95% CI, 2.6–3.8). Women faced a higher hazard of stroke than men (hazard ratio, 1.6; 95% CI, 1.2–2.1), particularly hemorrhagic stroke (hazard ratio, 2.2; 95% CI, 1.4–3.4). Stroke was strongly associated with subsequent in-hospital mortality (hazard ratio, 6.1; 95% CI, 4.6–7.9). Conclusions—: The incidence of stroke after VAD implantation was 8.7% per year, and incident stroke was strongly associated with subsequent in-hospital mortality. Notably, ischemic stroke occurred at nearly twice the rate of hemorrhagic stroke. Women seemed to face a higher risk for hemorrhagic stroke than men.

1 August 2017 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
NPNeal Parikh
Neal Parikh
BNBabak B. Navi
Babak B. Navi
YSYecheskel Schneider
Yecheskel Schneider
AJArun Jesudian
Arun Jesudian
HKHooman Kamel
Hooman Kamel
Cirrhosis is associated with extrahepatic hemorrhagic and thrombotic processes, such as gastrointestinal bleeding1 and venous thromboembolism.2-4 The cerebrovascular complications of cirrhosis are comparatively less well understood. Early studies5,6 reported a reduced prevalence of stroke in patients with cirrhosis at the time of autopsy. More recent studies7-9 similarly found a reduced risk of all stroke and ischemic stroke, but these studies had small and narrowly defined study cohorts. With regard to hemorrhagic stroke, a previous study10 found that liver disease is associated with an increased risk of intracranial hemorrhage, but other studies11,12 have not found this to be the case. Because of the continued uncertainty, we sought to assess the association between cirrhosis and various stroke types in a large, nationally representative sample of Medicare beneficiaries.

11 June 2020 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
SOSetareh Salehi Omran
Setareh Salehi Omran
NPNeal Parikh
Neal Parikh
SPSharon Poisson
Sharon Poisson
JAJennifer Armstrong
Jennifer Armstrong
AMAlexander E. Merkler
Alexander E. Merkler
HKHooman Kamel
Hooman Kamel

1 March 2020 in Stroke
Verified
Journal Article
Closed access
PDF file
NPNeal Parikh
Neal Parikh
HKHooman Kamel
Hooman Kamel
BNBabak B. Navi
Babak B. Navi
CICostantino Iadecola
Costantino Iadecola
AMAlexander E. Merkler
Alexander E. Merkler
TSThorsten Steiner
Thorsten Steiner
Background and Purpose—: Cirrhosis—clinically overt, advanced liver disease—is associated with an increased risk of hemorrhagic stroke and poor stroke outcomes. We sought to investigate whether subclinical liver disease, specifically liver fibrosis, is associated with clinical and radiological outcomes in patients with primary intracerebral hemorrhage. Methods—: We performed a retrospective cohort study using data from the Virtual International Stroke Trials Archive–Intracerebral Hemorrhage. We included adult patients with primary intracerebral hemorrhage presenting within 6 hours of symptom onset. We calculated 3 validated fibrosis indices—Aspartate Aminotransferase–Platelet Ratio Index, Fibrosis-4 score, and Nonalcoholic Fatty Liver Disease Fibrosis Score—and modeled them as continuous exposure variables. Primary outcomes were admission hematoma volume and hematoma expansion. Secondary outcomes were mortality, and the composite of major disability or death, at 90 days. We used linear and logistic regression models adjusted for previously established risk factors. Results—: Among 432 patients with intracerebral hemorrhage, the mean Aspartate Aminotransferase–Platelet Ratio Index, Fibrosis-4, and Nonalcoholic Fatty Liver Disease Fibrosis Score values on admission reflected intermediate probabilities of fibrosis, whereas standard hepatic assays and coagulation parameters were largely normal. After adjusting for potential confounders, Aspartate Aminotransferase–Platelet Ratio Index was associated with hematoma volume (β, 0.20 [95% CI, 0.04–0.36]), hematoma expansion (odds ratio, 1.6 [95% CI, 1.1–2.3]), and mortality (odds ratio, 1.8 [95% CI, 1.1–2.7]). Fibrosis-4 was also associated with hematoma volume (β, 0.27 [95% CI, 0.07–0.47]), hematoma expansion (odds ratio, 1.9 [95% CI, 1.2–3.0]), and mortality (odds ratio, 2.0 [95% CI, 1.1–3.6]). Nonalcoholic Fatty Liver Disease Fibrosis Score was not associated with any outcome. Indices were not associated with the composite of major disability or death. Conclusions—: In patients with largely normal liver chemistries, 2 liver fibrosis indices were associated with admission hematoma volume, hematoma expansion, and mortality after intracerebral hemorrhage.